Skip to content

Reminder for DEA Registrants in California: October 2, 2018 is the Compliance Date for CURES Monitoring

Beginning October 2, a California healthcare practitioner registered with the U.S. Drug Enforcement Administration (DEA) and authorized to prescribe, order, administer, or furnish a controlled substance must consult the Controlled Substance Utilization Review and Evaluation System (CURES) 2.0 for a patient’s controlled substance history. The DEA-registered practitioner must do so no earlier than 24 hours, or the previous business day, before prescribing a Schedule II – IV controlled substance to the patient for the first time and at least once every 4 months thereafter if the substance remains part of the patient’s treatment.


The new requirements exempts a practitioner from this requirement under specified circumstances, including when prescribing, ordering, administering, or furnishing a controlled substance 1) to a patient receiving hospice care, 2) to a patient admitted to a specified facility for use while on facility premises, or 3) to a patient as part of a treatment for a surgical procedure in a specified facility if the quantity of the controlled substance does not exceed a non-refillable 5-day supply of the controlled substance.

Since 1992, OSHA Review, Inc. has provided dental professionals with comprehensive programs to support regulatory compliance and infection control. We are a registered continuing education provider in the state of California, specializing in Dental Practice Act, infection control, and OSHA training.

Back To Top